Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 2
Review
Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,891 | Dovepress* | 10,891+ | 2,515 | 13,406 | |
Totals | 10,891 | 2,515 | 13,406 | ||
*Since 21 May 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on Google Scholar